TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/26/25 16:15 | 8/22/25 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | 3 | 3 | S | -540 | 13.79 | 0 | -39 | 2,057 | D | |||||||||||||||
8/21/25 16:19 | 8/20/25 | SEER | Seer, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | 3 | 3 | S | -146 | 2.06 | 0 | -71 | 1,758 | D | |||||||||||||||
8/21/25 10:17 | 8/19/25 | MTD | Mettler Toledo International Inc/ | DE | Electr | LabEq | Laboratory Analytical Instrum | 3 | 4 | S.d | -2,371 | 1,297.9 | 0 | -2 | 58 | D | |||||||||||||||
8/20/25 16:06 | 8/18/25 | PACB | Pacific Biosciences of California, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | 1 | 1 | S | -35 | 1.31 | 0 | -27 | 1,920 | D | |||||||||||||||
8/6/25 16:32 | 8/5/25 | AVTR | Avantor, Inc. | Electr | LabEq | Laboratory Analytical Instrum | 1 | 1 | S | -40 | 11.39 | 0 | -3 | 55 | D | ||||||||||||||||
8/4/25 16:15 | 8/1/25 | A | Agilent Technologies, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | 2 | 3 | S | -405 | 115.16 | 0 | -4 | 39 | D | |||||||||||||||
7/15/25 16:37 | 7/11/25 | RPID | Rapid Micro Biosystems, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | 1 | 2 | S.m | -196 | 3.41 | 0 | -57 | 971 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |